Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Cancer Gene Therapy
|
May 3, 2001
Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs
A Märten, C Ziske, B Schöttker, et al.
British Journal of Cancer
|
November 27, 1999
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
I G Schmidt-Wolf, S Finke, B Trojaneck, et al.
Transplantation
|
March 9, 2000
In vitro analysis of verapamil-induced immunosuppression: potent inhibition of T cell motility and lymphocytic transmigration through allogeneic endothelial cells
R A Blaheta, N P Hailer, N Brude, et al.
Journal of Virology
|
October 24, 2000
Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif
C M Leutenegger, F S Boretti, C N Mislin, et al.
BMC Veterinary Research
|
June 24, 2015
Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent
Christiane L Schnabel, P Steinig, M Koy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2018
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study
M Thomas, S Ponce-Aix, A Navarro, et al.
AIDS (London, England)
|
September 14, 2000
Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression
F S Boretti, C M Leutenegger, C Mislin, et al.
Human Gene Therapy
|
February 15, 2001
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial
B Wittig, A Märten, T Dorbic, et al.
Mucosal Immunology
|
August 3, 2017
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
A R Krarup, M Abdel-Mohsen, M H Schleimann, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Cancer Gene Therapy
|
May 3, 2001
Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs
A Märten, C Ziske, B Schöttker, et al.
British Journal of Cancer
|
November 27, 1999
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
I G Schmidt-Wolf, S Finke, B Trojaneck, et al.
Transplantation
|
March 9, 2000
In vitro analysis of verapamil-induced immunosuppression: potent inhibition of T cell motility and lymphocytic transmigration through allogeneic endothelial cells
R A Blaheta, N P Hailer, N Brude, et al.
Journal of Virology
|
October 24, 2000
Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif
C M Leutenegger, F S Boretti, C N Mislin, et al.
BMC Veterinary Research
|
June 24, 2015
Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent
Christiane L Schnabel, P Steinig, M Koy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2018
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study
M Thomas, S Ponce-Aix, A Navarro, et al.
AIDS (London, England)
|
September 14, 2000
Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression
F S Boretti, C M Leutenegger, C Mislin, et al.
Human Gene Therapy
|
February 15, 2001
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial
B Wittig, A Märten, T Dorbic, et al.
Mucosal Immunology
|
August 3, 2017
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
A R Krarup, M Abdel-Mohsen, M H Schleimann, et al.
Page
of 9